Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eran Mick

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|August 27, 2021
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDSAartik Sarma, Stephanie A Christenson, Ashley Byrne, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract TranscriptomesAartik Sarma, Stephanie A Christenson, Beth Zha Shoshana, et al.
Stem Cell Reports|February 24, 2023
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variantsLisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Eclinicalmedicine|September 1, 2020
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19Sachin J Shah, Peter N Barish, Priya A Prasad, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19Sachin J Shah, Peter N Barish, Priya A Prasad, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|August 27, 2021
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDSAartik Sarma, Stephanie A Christenson, Ashley Byrne, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19Alexandra Tsitsiklis, Beth Shoshana Zha, Ashley Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract TranscriptomesAartik Sarma, Stephanie A Christenson, Beth Zha Shoshana, et al.
Stem Cell Reports|February 24, 2023
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variantsLisiena Hysenaj, Samantha Little, Kayla Kulhanek, et al.
Eclinicalmedicine|September 1, 2020
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19Sachin J Shah, Peter N Barish, Priya A Prasad, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19Sachin J Shah, Peter N Barish, Priya A Prasad, et al.
Iscience|October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingJason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
Pageof 4